Biofrontera Inc.
BFRI· Nasdaq
BFRIBiofrontera Inc.
Filed Aug 11, 2023 · 10-Q · 42 days after period end · 0001493152-23-027701
| Metric | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|
| Revenue | $5.85M | $4.46M | $5.86M |
| Net Income | -$9.84M | -$850.00K | -$3.66M |
| EPS Diluted | -$7.23 | -$0.90 | -$0.46 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biofrontera Inc. · CIK 1858685 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 11, 2023 · 42 d after period end
